Jorge Conde Biography

Jorge Conde is a general partner at Andreessen Horowitz where he leads investments at the cross section of biology computer science and engineering. Prior to joining a16z Jorge served as Chief Strategy Officer for Syros (NASDAQ: SYRS) which is advancing a new wave of medicines that control expression of disease-driving genes to treat cancer and other diseases. He previously served as the company's Chief Financial Officer and Chief Product Officer leading the platform strategy for Syros' novel gene regulation technology. Jorge also cofounded Knome a human genome interpretation company acquired by Tute Genomics in 2015. Earlier in his career Jorge worked in marketing and operations at MedImmune and as a biotechnology investment banker at Morgan Stanley. Jorge holds an MBA from Harvard Business School an MS from the Harvard-MIT Division of Health Sciences and Technology and a BA in Biology from Johns Hopkins University. Jorge was named one of the top 35 young innovators in the world by the MIT Technology Review and is a Henry Crown Fellow of the Aspen Institute and a member of the Aspen Global Leadership Network. He serves on the board of the Museum of Science Boston.

As a renowned expert and highly sought-after speaker, Jorge Conde's expertise is in high demand. To book Jorge Conde for your next event, conference, or workshop, please contact our speaker booking agency. Our experienced team will work closely with you to understand your specific needs and help secure Jorge Conde's participation. With our professional guidance and seamless booking process, you can ensure a memorable and impactful experience for your audience. Don't miss the opportunity to engage your audience with Jorge Conde's compelling insights and inspire positive change within your organization. Fill out the booking request form to take the first step in securing Jorge Conde for your next speaking engagement.